LIVE

KRO

Kronos Worldwide, Inc.

KRO

NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $705.3M

$5.97

-2.61%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$4.08 - $7.89

P/E

-5.14

Fwd P/E

-91.85

Beta

0.96

Div Yield

3.26%

Avg Vol

301.1K

Shares Out

115.1M

Mkt Cap

$705.3M

Price action

Price chart

Down 6.8% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

5 reasons

  • Century-old brand heritage and operational expertise since 1916
  • Diversified product portfolio reducing market concentration risk
  • Global production and distribution network across Europe, North America, and Asia Pacific
  • Integrated supply chain from raw materials to finished specialty chemicals
  • Technical service capabilities supporting customer formulation and application needs

Bear Case

1 risk

  • Average volatility.

Growth

Stable outlook

Rising global demand for TiO2 in emerging markets and developing economies

Value

Deep value opportunity - significant discount to Specialty Chemicals peers

Momentum

Stable

-3.8% over 3m

Quality

Thin

Mixed fundamentals

Dividend

Solid

3.26% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 5, 2026

Q2 26 RECAP

MAY 6, 2026

Reported EPS of -$0.04 vs -$0.33 consensus (+87.9% surprise). Revenue of $509.8M vs $524.0M expected (-2.7%).

EPS beat +87.9%
Revenue miss

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+87.9%

Next: May 5, 2026

Revenue trend · last 8Q

+6%

+2%

-1%

-6%

-1%

+4%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$500.5M

$484.7M

$423.1M

$489.8M

$494.4M

$456.9M

$418.3M

$509.8M

Margins · last 8Q

Gross

Operating

Profit

-0.9%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

No analyst coverage on file for this stock yet.

vs Industry

How KRO stacks vs Chemicals - Specialty

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.